Net Cash Provided by (Used in) Operating Activities |
-289K |
USD |
-72.5% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
61K |
USD |
|
Q1 2023 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2022 |
FY 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-289K |
USD |
-171% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
739K |
USD |
+22% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
716K |
USD |
+162% |
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Gross |
716K |
USD |
+162% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Deferred Federal Income Tax Expense (Benefit) |
-44.1K |
USD |
|
Q3 2022 |
Q3 2022 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Current Federal Tax Expense (Benefit) |
255K |
USD |
|
Q3 2022 |
Q3 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |